skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: ClinicalKey remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes
The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes
Material Type:
Artigo 		Adicionar ao Meu Espaço

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

Bonanno, L. ; Pavan, A. ; Dieci, M.V. ; Di Liso, E. ; Schiavon, M. ; Comacchio, G. ; Attili, I. ; Pasello, G. ; Calabrese, F. ; Rea, F. ; Favaretto, A. ; Rugge, M. ; Guarneri, V. ; Fassan, M. ; Conte, P.F.

European journal of cancer (1990), 2018-09, Vol.101, p.191-200 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards
Material Type:
Artigo 		Adicionar ao Meu Espaço

Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards

Danesi, R. ; Fogli, S. ; Indraccolo, S. ; Del Re, M. ; Dei Tos, A.P. ; Leoncini, L. ; Antonuzzo, L. ; Bonanno, L. ; Guarneri, V. ; Pierini, A. ; Amunni, G. ; Conte, P.

ESMO open, 2021-04, Vol.6 (2), p.100040-100040, Article 100040 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy

Berardi, R. ; Torniai, M. ; Cona, M.S. ; Cecere, F.L. ; Chiari, R. ; Guarneri, V. ; La Verde, N. ; Locati, L. ; Lorusso, D. ; Martinelli, E. ; Giannarelli, D. ; Garassino, M.C.

ESMO open, 2021-04, Vol.6 (2), p.100053-100053, Article 100053 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review

Miglietta, F. ; Fabi, A. ; Generali, D. ; Dieci, M.V. ; Arpino, G. ; Bianchini, G. ; Cinieri, S. ; Conte, P.F. ; Curigliano, G. ; De Laurentiis, M. ; Del Mastro, L. ; De Placido, S. ; Gennari, A. ; Puglisi, F. ; Zambelli, A. ; Perrone, F. ; Guarneri, V.

Cancer treatment reviews, 2023-03, Vol.114, p.102511-102511, Article 102511 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study

Bosio, A. ; Cerretti, G. ; Padovan, M. ; Caccese, M. ; Denaro, L. ; Chioffi, F. ; Della Puppa, A. ; Aldegheri, V. ; Guarneri, V. ; Zagonel, V. ; Lombardi, G.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2023-05, Vol.35 (5), p.e319-e327 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study
Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study

Normanno, Nicola ; De Luca, Antonella ; Abate, Riziero Esposito ; Morabito, Alessandro ; Milella, Michele ; Tabbò, Fabrizio ; Curigliano, Giuseppe ; Masini, Cristina ; Marchetti, Paolo ; Pruneri, Giancarlo ; Guarneri, Valentina ; Frassineti, Giovanni L. ; Fasola, Gianpiero ; Adamo, Vincenzo ; Daniele, Bruno ; Berardi, Rossana ; Feroce, Florinda ; Maiello, Evaristo ; Pinto, Carmine

European journal of cancer (1990), 2023-07, Vol.187, p.174-184 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study
Material Type:
Artigo 		Adicionar ao Meu Espaço

T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study

Schettini, F. ; Conte, B. ; Buono, G. ; De Placido, P. ; Parola, S. ; Griguolo, G. ; Fabi, A. ; Bighin, C. ; Riccardi, F. ; Cianniello, D. ; De Laurentiis, M. ; Puglisi, F. ; Pelizzari, G. ; Bonotto, M. ; Russo, S. ; Frassoldati, A. ; Pazzola, A. ; Montemurro, F. ; Lambertini, M. ; Guarneri, V. ; Cognetti, F. ; Locci, M. ; Generali, D. ; Conte, P. ; De Placido, S. ; Giuliano, M. ; Arpino, G. ; Del Mastro, L.

ESMO open, 2021-04, Vol.6 (2), p.100099-100099, Article 100099 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial

Guarneri, Valentina ; Giorgi, Carlo Alberto ; Cinieri, Saverio ; Bengala, Carmelo ; Mariani, Gabriella ; Bisagni, Giancarlo ; Frassoldati, Antonio ; Zamagni, Claudio ; De Rossi, Costanza ; Amoroso, Vito ; Andreetta, Claudia ; Ferro, Antonella ; Zambelli, Alberto ; Gori, Stefania ; Garrone, Ornella ; Dieci, Maria Vittoria ; Orlando, Laura ; Pastina, Ilaria ; Beninato, Teresa ; Moretti, Gabriella ; Genovesi, Elisa ; Cinefra, Margherita ; Vicini, Roberto ; Magni, Giovanna ; De Salvo, Gian L. ; Conte, PierFranco

European journal of cancer (1990), 2021-09, Vol.154, p.21-29 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)
A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer (PEMBRACA)

Cortesi, L. ; Venturelli, M. ; Cortesi, G. ; Caggia, F. ; Toss, A. ; Barbieri, E. ; De Giorgi, U. ; Guarneri, V. ; Musolino, A. ; De Matteis, E. ; Zambelli, A. ; Bisagni, G. ; Dominici, M.

ESMO open, 2023-04, Vol.8 (2), p.101207-101207, Article 101207 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee
Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee
Material Type:
Artigo 		Adicionar ao Meu Espaço

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): A European survey conducted by the European Society for Medical Oncology (ESMO) Young Oncologists Committee

Califano, R ; Karamouzis, M.V ; Banerjee, S ; de Azambuja, E ; Guarneri, V ; Hutka, M ; Jordan, K ; Kamposioras, K ; Martinelli, E ; Corral, J ; Postel-Vinay, S ; Preusser, M ; Porcu, L ; Torri, V

Lung cancer (Amsterdam, Netherlands), 2014-07, Vol.85 (1), p.74-80 [Periódico revisado por pares]

Oxford: Elsevier

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.